We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.25 | 2.20 | 2.30 | 2.25 | 2.25 | 2.25 | 1,451,687 | 07:48:42 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -2.37 | 12.22M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/9/2024 08:42 | Shares will rise 50% to 100% upon news of further contract wins and or EVA for MT-RNR1 | z1co | |
17/9/2024 08:30 | Zico is not only a liar, he's a little guy from a bedsit trading in chunks of £100. I politely asked him which trades were his, and when I was closing my shorts, he refused to me (even though he claimed he was buying big). With high sight, I should have kept my big shorts till 0.5p | jane1984 | |
17/9/2024 08:26 | Did Zico pass my shorts closure as long as "millions of shares"? Yes he did. Now that GDR is cheaper, he should buy 5m shares and tell us 5 minutes in advance. | jane1984 | |
17/9/2024 07:54 | Beeksy You muppet why don't you just keep posting on the other FRED. | z1co | |
17/9/2024 07:46 | Jane , LOL I have more than enough and if i want to buy more i will. I'm not LIAR like you buying shares at around 2.80p and then posting they were shorts. So why don't you kindly get yourself fkd. Hope that helps you | z1co | |
17/9/2024 07:28 | Why does Zico not buy the millions now and tell us he is buying? Rather passing other people's trades as his. Show us he does not trade in chunk of £100 | jane1984 | |
17/9/2024 06:53 | The Labour government are making NHS their number one priority. hxxps://news.sky.com | themachine2 | |
17/9/2024 06:47 | The CYP2C19-ID Kit was only approved on 31/07/2024 and withing two weeks the company won initial orders in excess of £100,000 with Greater Manchester's Comprehensive Stroke Centre. Over the coming weeks/months more NHS hospitals will implement the test. | z1co | |
17/9/2024 06:43 | KIngston posting LIES yet again. By implementing CYP2C19 genotyping in IS/TIA the NHS could save approximately £91m and £454m over one and five years respectively. | z1co | |
17/9/2024 01:59 | The share price is hanging by a thread, but the thread will break. As soon as it falls below 2 p it will quickly drop to 1.5 p (the previous placing price). Investors are aware that there is only a sales order of £100k. I reckon that the company will announce the next placing at 1 p a share in March 2025 before the cash runs out. Those talking of savings for the NHS if it uses GDR's devices are too optimistic. The real world does not operate like that. Essentially, the NHS is spreading its resources too thinly on too many things. | kingston78 | |
16/9/2024 11:36 | A few more contract wins will see the price rise to over 4p again. | themachine2 | |
16/9/2024 11:32 | Wrong thread , you wanna be ramping your losses at GEX , it's nearly 10p now.! Be a nice troll and hop along. | themachine2 | |
16/9/2024 11:12 | put a sock in it for gods sake | purple11 | |
16/9/2024 11:11 | Dr Gino Miele, CEO of genedrive plc, said after winning 1st orders for CYP2C19 Kit: "These initial first-sales of our CYP2C19 ID-kit in the UK to one of the largest stroke centres nationally is a key initial milestone in our CYP2C19 commercialisation strategy, and further strengthens our pharmacogenetic positioning strategy in emergency care more broadly. We look forward to increasing implementation of our CYP2C19 test in the UK NHS and internationally to the benefit of both healthcare systems financially and improvement of patient outcomes." | z1co | |
16/9/2024 11:05 | By implementing CYP2C19 genotyping in IS/TIA the NHS could save approximately £91m and £454m over one and five years respectively. | z1co |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions